ANANDA Scientific Announces a Clinical Trial Evaluating Nantheia™ ATL5, in the treatment of Co-Occurring Opioid Use Disorder and Chronic Pain
6
AD
ANANDA Scientific Inc. , a research-focused biopharmaceutical company, today announced the commencement of a clinical trial evaluating Nantheia™ ATL5, an investigational drug using cannabidiol (CBD), leveraging ANANDA’s proprietary delivery techn…
– 출처 :
https://www.newswire.co.kr/newsRead.php?no=998796&sourceType=rss
AD